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Induction of MHC Class I Expression
by the MHC Class II Transactivator CIITA
Brian K. Martin,*² Keh-Chuang Chin,*³ expression, since mutantcell lines containingall of these
proteins still do not express class II MHC genes (MaoJohn C. Olsen,§ Cheryl A. Skinner,*
et al., 1993). This suggests the existence of a missingAnup Dey,‖ Keiko Ozato,‖ and Jenny P.-Y. Ting*²
link that may be a global regulator of class II expression.*Lineberger Comprehensive Cancer Center
The class II transactivator (CIITA), identified as a genetic²Department of Microbiology±Immunology
defect of the bare lymphocyte syndrome (BLS), repre-³Department of Biochemistry and Biophysics
sents such a global regulator.§Department of Medicine
BLS patients have a pan-deficiency in class II expres-Cystic Fibrosis/Pulmonary Research
sion and suffer from severe immunodeficiency (reviewedand Treatment Center
by Mach, 1995; Mach et al., 1996). B cells from oneUniversity of North Carolina at Chapel Hill
complementation group of BLS have an occupied classChapel Hill, North Carolina 27599±7295
II MHC promoter that is indistinguishable from that of‖Laboratory of Molecular Growth Regulation
B cells expressing class II, as assessed by in vivo foot-National Institute of Child Health
printing (Kara and Glimcher, 1991). Complementationand Human Development
cloning of the defective gene in this group of BLS ledNational Institutes of Health
to the identification of CIITA (Steimle et al., 1993). ThisBethesda, Maryland 20892
novel gene was analyzed and found to be a global regu-
lator of the class II MHC genes. De novo expression of
CIITA facilitates expression of the genes encoding all
Summary of the classic MHC class II a and b chains (DR, DP, and
DQ) (Steimle et al., 1993), Ii, and the DM proteins (Chang
Major histocompatibility complex (MHC) class I±defi- et al., 1994; Chin et al., 1994; Steimle et al., 1994; Chang
cient cell lines were used to demonstrate that theMHC and Flavell, 1995). An N-terminal domain in the protein
class II transactivator (CIITA) can induce surface ex- can serve as a transcriptional activator when fused to
pression of MHC class I molecules. CIITA induces the the GAL4 DNA-binding domain (Riley et al., 1995; Zhou
promoter of MHC class I heavy chain genes. The site and Glimcher, 1995), but CIITA does not have an intrinsic
a DNA element is the target for CIITA-induced trans- DNA-binding activity (Steimle et al., 1993). Mice with a
activation of class I. In addition, interferon-g (IFNg)± defective CIITA gene modified by homologous recombi-
induced MHC class I expression also requires an intact nation have a phenotype similar to that of BLS patients
site a. The G3A cell line, which is defective in CIITA (Chang et al., 1996). The function of CIITA in class II MHC
induction, does not induce MHC class I antigen and expression is currently an area of vigorous investigation;
promoter in response to IFNg. Trans-dominant±neg- however, the effect of CIITA on MHC class I expression
ative forms of CIITA reduce class I MHC promoter has not yet been noted.
MHC class I antigen presentation, in general, func-function and surface antigen expression. Collectively,
tions by presentation of cytosol-derived peptides tothese data argue that CIITA has a role in class I MHC
CD81 T lymphocytes. Class I MHC molecules generallygene induction.
have a ubiquitous expression pattern (reviewed by
Burke and Ozato, 1989; Tatake and Zeff, 1993). TheIntroduction
level of class I MHC proteins can be regulated by many
immune cytokines, including the IFNs. The molecularMajor histocompatibility complex (MHC) class I and
regulation of the MHC class I molecules has been wellclass II molecules are cell surface glycoproteins that are
studied (reviewed by Singer and Maguire, 1990; Tinginvolved in the antigen presentation arm of the immune
and Baldwin, 1993). There is a high degree of cross-
response. MHC class II molecules are composed of het-
species conservation of key elements of the class I MHC
erodimeric a and b chains. These molecules, in associa-
promoter/enhancer (reviewed by Vallejo and Pease,
tion with the accessory molecules Invariant chain (Ii) 1995). Figure 1 shows a schematic diagram of the con-
(Cresswell, 1994) and the DM proteins (Denzin and served elements of the class I MHC promoter. The region
Cresswell, 1995; Sherman et al., 1995; Sloan et al., 1995), that extends from 2200 to 2140 bp is referred to as the
facilitate the presentation of predominantly extracellular class I regulatory complex. Included in this area is a
antigens to CD41 T lymphocytes. Expression of proteins consensus NF-kB binding sequence, the region I en-
in the class II MHC pathway is generally restricted to hancer (Shirayoshi et al., 1987), and region II, which
professional antigen-presenting cells, although their ex- binds RXR hormone receptors and mediates the retinoic
pression can be induced by a number of stimuli, the acid response in some cell types and functions as a
most potent being interferon-g (IFNg) (reviewed by low-level enhancer in others (Segars et al., 1993). The
Glimcher and Kara, 1992; Ting and Baldwin, 1993; Mach IFN consensus sequence (ICS), which contains the IFN
et al., 1996). The molecular regulation of the MHC class response element, functions in the IFN-induced expres-
II genes has been well studied, and several factors that sion of class I genes (Sugita et al., 1987). Additional
contribute to constitutive and IFNg- induced expression upstream sites, including silencer and enhancer ele-
have been identified (reviewed by Glimcher and Kara, ments, also play a role in class I MHC regulation (Maguire
1992; Ting and Baldwin, 1993; Mach et al., 1996). How- et al., 1992; Saji et al., 1992). Results from in vivo foot-
printing of HLA and H-2 genes in the region from 2200ever, these factors are not sufficient to reconstitute DRA
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Figure 1. The MHC Class I Promoter
The conserved elements of the class I pro-
moter are indicated by boxes, and the factors
known or hypothesized to bind to the ele-
ments are presented under their respective
sites. The numbers represent the location of
the respective sites in the mouse Ld promoter.
to 2100 bp identified footprints in region I and in the of CIITA in class I MHC expression, a retroviral vector
expressing human CIITA was transduced into cell linesICS (Dey et al., 1992). However, the strongest footprints
are in site a, a CRE-like sequence involved in class I that express low levels of MHC class I proteins. The
resultant stably transduced polyclonal populations wereregulation in some cells but not others (Dey et al., 1992).
Most studies addressing the role of CIITA have not analyzed by flow cytometry using a rat anti-mouse H-2
antibody for murine cell lines and mouse anti-humannoted major effects of CIITA on class I MHC expression.
However, a rigorous and systematic investigation has HLA-A, -B, and -C for human cell lines (Figure 2 and
Table 1). The Line1 murine lung carcinoma cell has anot been done. One report indicates that the ability of
IFNg to stimulate MHC class I expression is attenuated very low basal MHC class I expression that is highly
inducible by IFNg (Pulaski et al., 1993). Expression of(Mao et al., 1993) in a fibrosarcoma with a known defect
in CIITA expression (Chin et al., 1994). Others have CIITA in this cell line led to a significant increase in the
levels of class I molecules on the cell surface (Figureshown that CIITA expression (or lack thereof) did not
modulate class I expression. However, in none of these 2A). Histogram analysis demonstrated a 3-fold increase
in the mean channel fluorescence (MCF) (Table 1). In-reports was a comprehensive evaluation of effect of
CIITA on class I expression undertaken. creased class I expression was confirmed by examining
the expression of class I and class II on monoclonesFollowing the lead of Mao et al. (1993), we extended
studies of CIITA-induced MHC class I expression to a derived from CIITA-transduced Line1 cells. In all cases,
clones that had high class II expression had increasednumber of cell lines. To assess the effect of CIITA on
MHC class I expression, we examined the levels of MHC class I expression as well (up to a 30-fold induction of
class I expression; data not shown).class I after transducing cells with retrovirus containing
CIITA. The results show that CIITA enhances the expres- In a second murine tumor with low class I expression,
the melanoma B16-F1 (Chen et al., 1994), CIITA inducedsion of surface MHC class I antigens and transactivates
the promoter. Transactivation of the class I MHC pro- class I levels 2.4-fold (Figure 2A and Table 1). However,
CIITA did not induce class I MHC expression on themoter by CIITA is specifically mediated by site a. The
physiological importance of site a is also observed in mouse sarcoma SaI, which has high constitutive levels
of surface MHC class I (Figure 2A and Table 1) (Ostrand-the native IFNg inductionof MHC class Ipromoter. Using
various deletion and point mutation constructs of CIITA, Rosenberg et al., 1990). These data show that human
CIITA can induce MHC class Isurface protein expressionwe identified trans-dominant mutants of CIITA that
equally decreased class I and II MHC antigens. These in murine tumor cells that are deficient in the expression
of MHC class I.studies show that CIITA expression is important in class
II antigen expression and in addition may have a signifi- These studies were extended to the human cell lines
K562 (chronic myelogenous leukemia) and MCF-7cant effect on class I MHC antigens.
(breast carcinoma). K562 has very low class I MHC ex-
pression, which lends to its use as a natural killer cellResults
target (Ramirez et al., 1992), while MCF-7 has modest
amounts of HLA on the cell surface (Dolo et al., 1995).Transduction of CIITA into Class I MHC Negative
Cell Lines Induces Surface Class I Expression As shown in Figure 2B and Table 1, CIITA induced high
levels of class I in the K562 cell line, demonstrating anSeveral studies have shown that de novo expression of
CIITA in class II MHC deficient cell lines leads to the 11.9-fold induction over the vector-transduced poly-
clonal population. MCF-7 cells have a modest constitu-induction of all known genes in the class II antigen pre-
sentation pathway (Chang et al., 1994; Chin et al., 1994; tive level of class I MHC, which was not changed by the
introduction of CIITA (Figure 2B and Table 1). TheseSteimle et al., 1994; Kern et al., 1995; Chang and Flavell,
1995). In the studies that examined HLA expression, it data demonstrate that CIITA can induce MHC class I
proteins on the surfaces of both human and murine classwas reported that the expression of CIITA had no effect
on class I MHC molecules (Zhou and Glimcher, 1995; I±deficient cell lines.
Chang et al., 1996). However, those studies were con-
ducted using cells and cell lines that have high levels CIITA Induces Expression of MHC Class I
Promoter±CAT Reporter Constructsof surface class I MHC expression, and it is possible
that changes in the levels of these proteins were masked The enhanced cell surface expression of MHC class I
in the previous experiments may have resulted eitherby the high background expression. To assess the role
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induction was due to transcriptional enhancement. K562
cells were cotransfected with H-2 Ld-CAT constructs,
which have been described previously (Driggers et al.,
1992), and either control or CIITA expression plasmids.
The K562 cell line was selected because it displayed
the highest inducible class I expression in response to
CIITA transduction. The results of these experiments
are shown in Figure 3. The CIITA expression vector en-
hanced CAT expression from full-length Ld-CAT1.4k by
approximately 8-fold when cotransfected with CIITA ex-
pression plasmid (Figure 3, row B). The Ld-CAT237 con-
struct, which contains the well-defined region I and ICS
enhancers, retained CIITA inducibility (Figure 3, row C).
This construct also showed higher basal expression
than did Ld-CAT1.4k, which agrees with previous reports
of a negative regulatory element in the upstream region
(Maguire et al., 1992; Saji et al.,1992). Ld-CAT123 deletes
both the region I and region II enhancers as well as
the ICS. Although the basal expression of Ld-CAT123 is
lowered relative to Ld-CAT237, cotransfection of CIITA
with Ld-CAT123 enhanced CAT expression to a level
similar to the full-length Ld-CAT1.4K construct. The aver-
age enhancement was approximately 7.5-fold (Figure 3,
row D). In addition, previously defined point mutations
in the class I control elements region I and region II also
retained the ability to be transactivated by CIITA (data
not shown). Further promoter deletion that gives rise to
the Ld-CAT60 construct resulted in very low basal activ-
ity and loss of CIITA transactivation (Figure 3, row E).
The only identifiable elements in Ld-CAT60 are a CCAAT
element and a degenerate TATA box (Driggers et al.,
Figure 2. Flow Cytometry Analysis of MHC Class I and Class II Ex- 1992). These data demonstrate that the site responsible
pression on Mouse and Human Tumor Cell Lines Transduced with
for CIITA inducibility is between 2123 and 260 bp in theCIITA
mouse Ld promoter. CIITA did not enhance transcriptionA human CIITA cDNA was cloned into the retroviral vector LXSNb
from the promoterless CAT construct (Figure 3, row A),and retrovirus produced in the packaging cell line PA317. Mouse
nor did CIITA enhance transcription from the pSV2-CATtumor cell lines (A) or human tumor cell lines (B) were transduced
reporter (data not shown), indicating that the transacti-with retrovirus (either empty vector, LXSNb, or CIITA-containing
vector, LCIITASN) followed by selection in G418. For all cell lines vation effect of CIITA is promoter specific.
except B16-F1, the resultant polyclonal population was analyzed
by flow cytometry. B16-F1 cells had very low class II expression Site a Is Responsible for CIITA-Induced
and the polyclonal pool was enriched for class II expression by two Class I Expressionrounds of magnetic bead selection. Dotted line, secondary antibody
Previously, a site between 2123 and 260 bp in bothalone control; solid line, cells transduced with vector alone; filled
the mouse and human class I promoters was shown tohistogram, cells transduced with CIITA.
exhibit a very strong in vivo footprint (Dey et al., 1992)
and this sequence was termed site a. The site was
from transcriptional or from posttranscriptional mecha- shown to contain a canonical AP-1/CRE±like sequence,
nisms. However, since CIITA has been identified as a although the binding complex was probably not a typical
transcriptional transactivator (Riley et al., 1995; Zhou Fos/Jun heterodimer since site a did not efficiently com-
pete for Fos/Jun binding to the AP-1 site from c-fosand Glimcher, 1995), we tested the hypothesis that the
Table 1. Mean Channel Fluorescence of MHC Class II and Class I Molecules on Retrovirally Transduced Cell Lines
Class II Class I
Cell Line Vector CIITA Fold Inductiona Vector CIITA Fold Inductiona
Line1 3.45 52.33 15.2 4.17 12.78 3.1
B16-F1 2.89 34.76 12.0 4.71 11.16 2.4
SaI 9.68 42.97 4.4 121.2 89.54 0.74
K562 2.64 116.41 44.1 3.03 36.63 11.9
MCF-7 4.54 51.15 11.3 88.76 84.84 0.96
The cell lines were transduced with the empty vector (LXSN) or with the CIITA-expressing vector (LCIITASN). Cells were selected with G418
and the resultant polyclonal populations were analyzed on a Becton-Dickenson FACScan. Data were quantitated using the Cyclops program.
aFold induction was calculated as mean channel fluorescence displayed by cells with CIITA divided by mean channel fluorescence of cells
with the empty vector.
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Figure 3. Promoter Deletion Analysis of CIITA-Induced MHC Class I Expression Using the Ld-CAT Promoter
Constructs were electroporated into K562 cells with equimolar amounts of vector control DNA (pcDNA3) or with the CIITA expression plasmid
(pCIITA). Constructs used were promoterless CAT (A), full-length Ld-CAT1.4k (B), and deletion constructs Ld-CAT237 (C), Ld-CAT123 (D), and
Ld-CAT60 (E). CAT activity is normalized to the percentage acetylation for CIITA-induced Ld-CAT1.4k, and error bars represent the standard
error of the mean of three separate experiments.
(Dey et al., 1992). To address the specific contribution sequence. As shown in Figure 5, IFNg induced the Kb
promoter (lane A). Deletion of site a in the Kb-CATDaof site a to CIITA-induced class I transcription, CIITA
construct resulted in the loss of IFNg inducibility (Figureinducibility of the Kb-CAT construct and that of a mutant
5, lane B). This indicates that in the 2fTGH cell line, siteconstruct (Kb-CATDa) containing a specific 6 bpdeletion
a is an element responsible for IFNg-induced MHC classin site a (Dey et al., 1992) were compared. As shown in
I gene expression. Taken together with the previousFigure 4 (row A), the Kb-CAT construct was strongly
observation that the CIITA up-regulation of the class Iinduced by CIITA. The Kb-CAT construct with the 6 bp
MHC promoter is also mediated by site a, this findingdeletion in site a showed enhanced basal CAT expres-
strongly suggests that CIITA is important in the physio-sion in the absence of CIITA (Figure 4, row B). When Kb-
logical IFNg induction of class I MHC.CATDa was cotransfected with CIITA, no enhancement
In a second experiment to address the physiologicalwas observed (compare Figure 4, row B). These data
significance of CIITA in IFNg-induced class I MHC ex-show that CIITA absolutely requires site a for induction
pression, the above- mentioned studies were extendedof MHC class I.
to the G3A cell line, which is a CIITA-defective mutant
line derived from a sister clone of 2fTGH (Chin et al.,
Physiological Tests of CIITA Induction
of MHC Class I
The previous data indicate that CIITA induces class I
MHC gene expression via site a. If CIITA is to play a
physiological role in the IFNg induction of class I genes,
the IFNg induction of class I MHC promoter should be
dependent on the presence of an intact site a. This
possibility has not been previously explored. To investi-
gate this scenario, the IFNg responsive fibrosarcoma
line, 2fTGH, was transfected with MHC class I promoter
constructs containing either an intact or mutant site a
Figure 5. Promoter Activity of MHC Class I Promoters Containing
Intact or Mutant Site a Sequences in Response to IFNg in the 2fTGH
and G3A Cell Lines
Cells were transfected with either wild type Kb promoter or the site
a±deleted Kb promoter, and at that time IFNg (300 U/ml) was added
to the cultures in half of the sample while the other half of each
sample was left untreated. Forty hours later the cells were harvested
and assayed for CAT activity. The fold induction is presented as the
Figure 4. CIITA Activates the Kb-CAT Promoter through Site a percentage acetylation of IFNg-treated cells divided by the percent-
age acetylation of untreated cells for each construct and cell line.The Kb-CAT (A) and Kb-CATDa (B) constructs were electroporated
into K562 cells with either vector control DNA (pcDNA3) or with the (A) Kb-CAT transfected into 2fTGH cells; (B) Kb-CATDa transfected
into 2fTGH cells; (C) Kb-CAT transfected into G3A cells; and (D) Kb-CIITA expression plasmid (pCIITA). CAT activity is normalized to the
percentage acetylation for CIITA-induced Kb-CAT, and error bars CATDa transfected into G3A cells. The error bars represent the
standard error of the mean of three separate experiments.represent the SEM of three separate experiments.
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Table 2. Attenuated IFNg Responsiveness of MHC Class I and
Class II Proteins in the 2fTGH and G3A Cell Lines
Fold Inductiona
Cell Line Class II Class I
2fTGH 16.6 2.3
G3A 1.4 1.2
Cells were treated with IFNg (300 U/ml) for 48 hr. They were analyzed
by fluorescence-activated cell sorting, and a comparison was made
of the MCF of unstimulated versus IFNg-treated protein levels for
each cell line.
aFold induction is the MCF of IFNg treated cells divided by the MCF
of untreated cells. MCF induction of class I in multiple experiments
ranged from 1.7- to 3.3-fold in 2fTGH.
1994). The lack of CIITA in this clone is correlated with
a lack of IFNg-enhanced class II MHC expression and
attenuation of class I MHC inducibility (Mao et al., 1993).
The lack of CIITA expression in this line correlates with
the lack of an IFNg enhancement of the Kb promoter
(Figure 5C). In addition, deletion of site a did not influ- Figure 6. Gel Shift Analysis of Proteins Interacting with Site a in
Line1 and K562 Cells with and without CIITAence basal promoter expression or IFNg inducibility in
Gels shifts were performed using untransduced Line1 cells (lanesthis cell line (Figure 5D). In a third set of experiments
2 and 3) and K562 cells (lanes 6 and 7) or a CIITA-transduced Line1to assess the physiological role of CIITA in the IFNg
clone (L1/LCIITSNF6) expressing high levels of MHC class I andinduction of class I genes, the expression of class I MHC
class II (lanes 4 and 5) and K562 polyclonal CIITA-transduced cells
antigens on 2fTGH and on G3A cells was compared. (lanes 8 and 9). A 31 bp probe encompassing the site a sequence
IFNg induced class I MHC antigens on the 2fTGH cells, was used in gel shift analysis (see Experimental Procedures for
whereas such an induction was not observed for G3A sequence). Self-competition used a 200-foldexcess of cold compet-
itor site a oligonucleotides (lanes 3, 5, 7, and 9). Arrows A and B(Table 2). It must be emphasized that although the 2.3-
indicate gel shift complexes with similar migration patterns betweenfold induction by IFNg is modest, by absolute numbers
Line1 and K562 cells; arrow C indicates a complex unique to K562of molecules expressed on the cell surface, it is compa-
cells.
rable to that of MHC class II (MCF after IFNg treatment
changed from 2.3 to 48 for class II and from 43 to 99
for class I). This modest induction also agrees with the 4 and lane 6 to lane 8). However, the possibility cannot
be ruled out that CIITA induced changes that were subtleliterature (Sugita et al., 1987; Giuliani et al., 1995). An-
other laboratory has found that the transfection of CIITA or that were missed by the gel shift assay. Another
possible experimental approach would be to supershiftinto the G3A line enhanced class I expression (Gobin et
al., 1997 [Immunity, this issue]). These data indicate that the bands using CIITA antisera to reveal whether CIITA
is tethered on the DNA±protein complex. However, allthe lack of CIITA in the G3A cell line may be the principal
reason that G3A has an attenuated ability to induce MHC attempts to supershift the class II MHC promoter with
anti-CIITA antisera have been unsuccessful (data notclass I by IFNg.
shown), and hence this strategy was not used for the
class I promoter. Nonetheless, these data suggest eitherGel Shift Assays with Site a Show No Changes
in DNA-Binding Activity in Response that CIITA induces changes that are not detected by the
gel shift assay or that CIITA induction through the siteto CIITA Expression
The finding that the CIITA-specific induction of MHC a sequence does not result from new protein binding
to this site.class I gene expression mapped precisely to the site a
suggests the possible induction of a DNA-binding activ-
ity at this site or CIITA transactivation of a protein or Trans-Dominant±Negative CIITA Mutants Repress
the IFNg Induction of MHC Class I Expressionproteins already bound to this site. To investigate these
possibilities, gel shift experiments were performed using We have recently demonstrated that certain mutant
forms of CIITA function as trans-dominant±negative re-oligonucleotides spanning this sequence (Figure 6).
Several DNA-binding complexes were detected in ex- pressors of class II MHC promoter activation (Chin et
al., 1997). In other words, these mutants serve as decoytracts from both Line1 and K562 cells in control and
CIITA-transduced cells. These include two DNA±protein molecules that titrate out the wild-type CIITA, thus de-
creasing class II MHC promoter activation. The availabil-complexes of similar size in both Line1 and K562 ex-
tracts (Figure 6, arrows A and B) and another specific ity of these mutants suggests an additional approach
to examine the physiological contribution of CIITA toto K562 (Figure 6, arrow C). These complexes were spe-
cifically competed by cold competitor DNA (Figure 6, MHC class I induction by IFNg. To identify trans-domi-
nant±negative CIITA mutants of class I MHC, the effectlanes 3, 5, 7, and 9). The pattern of DNA±protein com-
plexes from control cells and CIITA-transduced cells of a panel of structural mutants was first tested on class
I promoters.was indistinguishable (Figure 6, compare lane 2 to lane
Immunity
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Figure 7. Comparison of the Reporter Activity of MHC Class II and Class I Promoters Induced by Different CIITA Mutant Constructs
CIITA mutant constructs were electroporated into K562 cells with either the class I Ld-CAT1.4k promoter or the class II DRA300CAT promoter.
The CAT levels were normalized to that induced by wild-type CIITA for MHC class I and class II, and the error bars reflect the standard error
of the mean of four (class I) or three (class II) separate experiments. Expression constructs contained the following CIITA sequences: (A) wild
type; (B) point mutation in the G1 domain; (C) 4 bp deletion in the G3 motif; (d) 4 bp deletion in the G4 modtif; (E) internal deletion in the
proline/serine/threonine-rich domains; and (F) 39 deletion in the CIITA coding sequence. The mutations are indicated by a space or marked
by an X. A, P, S, T represent acidic, proline, serine, and threonine-rich domains, respectively. The three black bars under the label GTP
represent the G1, G3, and G4 motifs. BLS2D is the region deleted in the CIITA BLS complementation group. Open bars, DRA300CAT reporter
cotransfected with indicated CIITA mutant; filled bars, Ld-CAT1.4k reporter cotransfected with indicated CIITA mutant. Normalized percentage
acetylation is relative to wild-type CIITA-induced expression levels for class II (open bars) and class I (filled bars).
Previous analysis of CIITA reveals that a domain ho- these mutant CIITA molecules were stably transfected
into the 2fTGH cell line. Cells were treated with IFNg formologous to the GTP-binding domains of a wide variety
of GTP-binding proteins is important in class II MHC 48 hr and then were analyzed by fluorescence-activated
cell sorting for surface MHC class II and class I expres-activation (Dever et al., 1987). Three motifs arecontained
within this domain: G1 (the phosphate-binding motif), G3 sion, relative to cells with stably integrated pcDNA3 vec-
tors. As shown in Table 3, all three constructs sup-(the Mg21 binding motif), and G4 (the guanine nucleotide
binding motif), according to conventional nomenclature. pressed MHC class II surface expression by 25% to
36%. The suppression is reproducible but incompleteTo assess the contribution of each of these homology
motifs to class I MHC activation, site-specific mutations and is most likely due to the low level of mutant CIITA
expressed in stable lines (K.-C. C., unpublished data).and deletions were generated and cotransfected with
either a class II MHC reporter construct (DRA300CAT) Similarly, these same constructs repressed MHC class
I surface expression 24% to 44%. These constructs didas a positive control or a class I MHC reporter construct
(Ld-CAT1.4k) (Figure 7, rows A±E). Mutations in all three not repress the expression of the class I associated
gene TAP1 (K.-C. C., unpublished data). Although theGTP motifs decreased CIITA induction of both class I
and II promoters to background levels (Figure 7, rows repression was incomplete, it mustbe viewed in context.
Since the response of MHC class II to IFNg has beenB±D). The 59 region of CIITA encodes proline/serine/
threonine±rich domains that have been shown to have shown to be absolutely dependent on CIITA expression,
the 25% to 36% repression in this experiment is indica-transactivation function (Riley et al., 1995; Zhou and
Glimcher, 1995). When all three domains were deleted tive of the repression that can be expected using this
experimental design. The observation that the MHC(Figure 7, row E), the level of activation was reduced to
background levels. Finally, a deletion in the 39-terminal class I levels are similarly repressed is good evidence
that CIITA is involved in MHC class I induction duringend of CIITA abolished class II and class I induction
(Figure 7, row F). These data suggest that the 39 se- an IFNg response.
quence in the CIITA gene is necessary for both MHC
class II and class I induction. These data collectively Discussion
indicate that the domains of CIITA that are necessary
for class I MHC induction are inseparable from those The CIITA gene has been characterized as a global regu-
lator of genes in the MHC class II antigen presentationinvolved in class II MHC induction.
These CIITA mutants were next tested for trans-domi- pathway (reviewed by Mach et al., 1996). In this role,
CIITA can transcriptionally induce all of the genes knownnant±negative suppression of class I MHC expression.
Three of these mutants, CIITA(D132±301), CIITA(1± to be involved in this pathway, including those encoding
class II a and b chains, Ii, and the DM molecules (Steimle1059), and GTP2(DDAYG), were highly efficient in sup-
pressing IFNg-induced levels of reporter gene driven by et al., 1993; Chang et al., 1994; Chin et al., 1994; Steimle
et al., 1995). In the present report we demonstrate thatthe Ld promoter (81% 6 1.7%, 79% 6 2.6%, and 72% 6
4.0% repression, respectively, compared to empty con- CIITA can induce MHC class I heavy chain in addition
to class II expression in cell lines that are low expressorstrol plasmid pcDNA3; mean 6 standard error of three
independent experiments). As an additional and more of class I MHC. This effect was observed as an increase
in cell surface expression in both mouse and humanphysiological approach, plasmid vectors expressing
Induction of MHC Class I by CIITA
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in IFNg-induced class I MHC gene expression, basalTable 3. Dominant-Negative Repression of MHC Class I and
Class II Levels in IFNg-Treated 2fTGH Cells levels of class I MHC gene expresion in cells from IRF-
12/2 mice are not decreased relative to that in cells fromPercentage Expression
control mice, even though the IRF gene is constitutively(relative to vector control)
expressed at low levels in the tissues that were exam-
DNA Construct Class II Class I
ined (Matsuyama et al., 1993; Reis et al., 1994). Nonethe-
pCDNA3 100 100 less, the finding in the knockout mice cannot be used to
CIITA (D132±301) 74 76 abolish the significance of IRF-1 in IFNg-induced class I
CIITA (1±1059) 77 56 MHC gene expression. A similar argument can be made
GTP2 (DDAYG) 64 75
here for CIITA. IRF-1 and CIITA may represent similar
2fTGH cells were stably transfected with the indicated construct. molecules that are IFNg induced and primarily important
Cells from the polyclonal pool were then treated with IFNg (300 in the IFNg induction of class I promoters.
U/ml) for 48 hr. They were analyzed by fluorescence-activated cell
The mapping and mutagenesis analysis clearly showsorting, and a comparison was made of the mean channel fluores-
that CIITA induces MHC class I transcription throughcence for each cell line. The absolute levels for the pCDNA3 con-
the site a sequence. The data show for the first time astructs were 94.0 for class II and 244.7 for class I.
pathway that requires site a. This sequence was origi-
nally identified as exhibiting a strong in vivo footprint in
cells and as an activation of both the H-2Kb and H-2Ld both splenic and brain cells (Dey et al., 1992). This site
promoters. Promoter deletion analysis localized site a is similar to the consensus sequence for the AP-1 site
as the region that is responsive to CIITA induction. and the cAMP response element (Lee and Masson,
Three lines of evidence are presented to validate the 1993). Gel shift analysis with site a probes revealed that
biological relevance of this observation. First, the class the complex formed with this site was eliminated upon
I promoter with a site a deletion did not respond to IFNg competition with the AP-1 site from the c-fos promoter;
or to CIITA, indicating the involvement of this site in however, the H-2Kb site a did not compete effectively
both a CIITA response and a normal IFNg response. against a consensus AP-1 probe for Jun/Fos binding.
Second, mutant cell lines with a defect in CIITA induction This suggests that the makeup of the site a binding
were defective in the IFNg induction of class I MHC complex is different than that of consensus AP-1 (Dey
promoter as well as surface antigen. Finally, trans-domi- et al., 1992). Previously, the region corresponding to site
nant±negative CIITA molecules reduced the expression a was shown to bind to an AP-1±like complex (Israel et
of surface MHC class I proteins to the same degree as al., 1989). Site a also binds to RXR heterodimers (Dey
class II MHC proteins. These trans-dominant mutants et al., 1992). Defining what is functionally binding and
also reduced class I promoter activity. Collectively, regulating this element is important for understanding
these data provide strong biological evidence that CIITA how CIITA regulates class I genes. One possible expla-
is involved in MHC class I gene regulation. nation for the lack of class I induction in some cell types
It should be underscored that in contrast to class II is that the makeup of proteins bound to the site a se-
MHC promoters, which are completely dependent on quence may differ among different cells. For instance,
CIITA for gene expression, class I MHC promoters are in the Line1 cell lines, the proteins bound may actively
expressed even in the absence of CIITA. However, CIITA interact with CIITA to induce mRNA expression, while
is required for optimal induction by IFNg, and the lack in the SaI cell line a different set a factors that do not
of CIITA correlates with the loss or decrease of IFNg- interact with CIITA may be bound at site a, and hence
induced class I MHC expression. These results do not there is no promoter induction. This possibility is being
negate the importanceof previous findings that the bind- actively investigated in our laboratory.
ing of IFNg-induced factors to the IFN response element The activation of an MHC class I promoter through
region of class I MHC promoters is important, but simply site a is interesting given that the promoters of the class
indicates that the IFNg induction of class I MHC requires I and class II genes are divergent. MHC class II promoter
multiple elements, including the site a element, which activity is critically dependent on the W, X, and Y ele-
mediates CIITA function. ments for constitutive expression in B cells and in IFNg-
On first glance, our finding contradicts previous find- induced expression in other cells (reviewed by Glimcher
ings that class I MHC expression appears to be normal and Kara, 1992; Ting and Baldwin, 1993). The class I
in B cell lines from BLS patients lacking CIITA and cells promoter is dependent on region I, ICS, and in some
from CIITA-knockout mice. However, these studies did cases the region II enhancer, in addition to upstream
not examine the cytokine-induced experimental condi- silencers and enhancers. The only sequence previously
tions used in this study. Our study also noted the lack shown to be involved in IFN induction is the ICS site
of a CIITA effect in some cell lines; most share the char- (reviewed by Burke and Ozato, 1989; Tatake and Zeff,
acteristics of high basal class I MHC expression. How- 1993). The MHC class I promoter does not contain se-
ever, analysis of the IFNg-responsive 2fTGH cell line quences homologous to the W or X1, nor does the class
and the CIITA-defective mutant G3A clearly shows a II promoter contain an ICS sequence. The X2 box of the
difference in class I MHC promoter activity that is linked class II promoter does contain sequences homologous
to CIITA. Therefore, it would be of interest to examine to site a. The core of the Kb site a sequence (TGACGC)
IFNg-induced class I levels in CIITA-deficient patient cell is also the core sequence of the X2 box of the DRA
lines. A parallel line of observation has been made for promoter, and the X2 box of DRA is important for CIITA-
the involvement of IRF-1 in class I MHC expression. induced class II expression in B cells (Zhou and
Glimcher, 1995). It is possible that a factor(s) binding toAlthough the IRF-1 gene product is shown to be involved
Immunity
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Experimental Proceduresthe X2 element in DRA and site a may be the common
link through which CIITA transactivates class I and class
Cell Lines and Culture ConditionsII MHC promoters.
The SaI and Line1 cell lines have been described previously (Os-
Experiments were also performed with b2m and TAP1 trand-Rosenberg et al., 1990; Pulaski et al., 1993). The B16-F1 mela-
promoters and revealed that CIITA did not induce their noma and the K562 chronic myelogenous leukemia cell lines were
obtained from the Lineberger Comprehensive Cancer Center Tissueexpression (data not shown). The induction of class I
Culture Facility (Chapel Hill, NC). The MCF-7 breast carcinoma wassurface expression is interesting given that b2m and
obtained from the American Type Culture Collection. SaI and B16-TAP1 are not similarly induced. It is well established that
F1 were maintained in DMEM (GIBCO-BRL, Gaithersburg, MD) with
b2m expression is required for surface expression of 7% fetal bovine serum (GIBCO±BRL). The other lines were main-
class I molecules, as has been demonstrated particu- tained in RPMI-1640 (GIBCO±BRL) with 7% fetal bovine serum. For
larly by the lack of surface H-2 expression in b2m knock- IFNg induction, cells were cultured in 300 U/ml recombinant human
IFNg (Genzyme, Cambridge, MA) for approximately 42 hr.out mice (Zijlstra et al., 1990). It has also been demon-
strated that lack of the peptide transporter TAP can also
Construction of Plasmid Constructslead to defects in surface class I expression (Restifo et
and Transduction of Cellsal., 1993; Cromme et al., 1994; Fehling et al., 1994; Keat-
The EcoRI fragment of the FLAG.CIITA8 construct was cloned into
ing et al., 1995). It is paradoxical that the induction of the EcoRI site of the LXSNb retroviral plasmid (Olsen and Sechelski,
MHC heavy chain alone can lead to an increase in cell 1995; Chin et al., 1997). The construction of the CIITA mutant plas-
surface expression of class I. We suggest that cells that mids is describedelsewhere (Chin et al., 1997). Production of retrovi-
rus was done as previously described(Olsen and Sechelski, 1995). Inare capable of CIITA-induced class I expression express
brief, plasmid DNA (either control vector or CIITA-containing vector)excess TAP and b2m molecules sufficient for higher
was transfected into the PA317 helper cell line via calcium phos-class I surface expression, whereas cells that are unre-
phate precipitation, and the following day the media were changed.
sponsive to MHC class I induction by CIITA may not Forty-eight hours after transfection, the supernatant was collected,
have excess TAP and b2m to support higher levels of sterilized by filtration, and stored at 2708C for later use.
surface expression. Further induction of surface class I Adherent cells were seeded on plates at 1 3 105 cells/35 mm
plate on the day before transduction. Suspension cultures in mid±logexpression would necessitate the up-regulation of these
growth phase were harvested on the day of transduction. Viral su-auxiliary molecules. This may place a restriction on the
pernatant (250 ml) with 8 mg/ml polybrene was added to 1 3 105ability of CIITA to induce class I expression at the cell
cells and incubated for 2 hr at 378C. After incubation the viral super-
surface. Therefore, it is possible that in cells in which natant was aspirated and replaced with fresh growth medium. Two
we have observed no increased surface class I expres- days after transduction, the cells were passaged 1:20 and placed
sion (SaI and MCF-7) may in fact have increased levels in selection media (400 mg/ml G418). The resultant polyclonal popu-
lation was then analyzed for class II expression. For the B16-F1of class I messenger RNA and intracellular protein. How-
melanoma cell line, analysis of the polyclonal population after CIITAever, in the absence of increased b2m, these cells are
transduction revealed that less than 5% of the population stainedunable to increase surface protein expression. Another
positive for class II (data not shown). Therefore, the cells were en-
question still to beanswered is what effect CIITA expres- riched for class II expression by two rounds of magnetic bead selec-
sion has on other class I and class I±like genes. tion (Dynal, Oslo, Norway). The antibody used in the selection was
These possibilities suggest three situations in which 7±16/17 (from Dr. J. F. Frelinger; see next section for antibody speci-
ficity).the expression of CIITA would be expected not to influ-
ence MHC class I expression. First, in certain cells with
Flow Cytometry Analysis of MHC Class Ivery high basal expression, the effect of CIITA may be
and Class II Expressionnegligible or difficult to detect. Second, the lack of ex-
The antibodies used for these studies were L243 mouse anti-human
cess molecules of TAP or b2m in some cells might not HLA-DR (hybridoma from ATCC) and mouse anti-human HLA-A, -B,
support increased MHC class I surface expression, even and -C (Pharmingen, San Diego, CA). The following were kindly
though CIITA induces heavy chain gene expression. provided by Dr. J. F. Frelinger: M1/42 (rat anti-mouse H-2), 34±7±23s
(anti H-2 Kd/Dd), BP1072.2 (anti I-Eb/I-Ab, reactive with haplotypesHowever, in cells with these accessory molecules in
d, b, p, q, u, and j), 7±16/17 (anti I, reactive with haplotypes p, b, k,excess, increased class I surface expression would be
q, r, s, and j). Secondary antibodies used were goat anti-mouseobserved with CIITA induction. Finally, in cells with AP-1
IgG±fluorescein isothiocyanate conjugate (Pharmingen) and goat
molecules that are not able to interact with CIITA, there anti-rat IgG±fluorescein isothiocyanate (Sigma, St. Louis, MO).
would be no enhanced class I mRNA expression and For flow cytometry, cells in log growth phase were harvested and
hence no increased surface expression. These possibili- washed twice with 13 PBS containing 0.1% sodium azide. The cells
were resuspended at 1 3 107 cells/ml and 100 ml was used for eachties suggest that the ability of CIITA to induce surface
sample. The cells were incubated for 30 min with diluted primaryclass I expression may be very cell specific.
antibody (20 ml/sample). The cells were washed three times withIn summary, the data presented in this report indicate
13 PBS±sodium azide and then incubated for 20 min in diluted
that CIITA may play a significant role in MHC class I secondary antibody (20 ml). The cells were washed three times with
transcription in cells with little or no class I expression. 13 PBS±sodium azide. The cells were either analyzed immediately
CIITA also activates class I surface expression in 2fTGH or fixed in 2% paraformaldehyde and stored for less than 1 week
for analysis.cells that have relatively high basal class I expression.
Flow cytometry was performed on a Becton-Dickinson FACScanInvestigation of the mechanism of CIITA-induced MHC
(San Jose, CA) using Cyclops software (Cytomation, Fort Collins,class I expression will be important to determine the
CO). Five thousand cells were analyzed for each sample.contribution of CIITA to the endogenous antigen presen-
tation pathway. This report demonstrates that CIITA Plasmids and Transfection
plays a greater role in the regulation of genes involved The Ld-CAT1.4k and its derivatives (Driggers et al., 1992), the Kb-CAT
in both antigen presentation pathways than previously and its derivative (Dey et al., 1992), and the DRA300CAT (Sherman et
al., 1987) plasmids have been previously described.believed.
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For transfections, K562 cells were in mid±log growth phase. Cells effect of B7 costimulation on T cell-mediated tumor immunity. J.
Exp. Med. 179, 523±532.were harvested and resuspended in complete media at a concentra-
tion of 1 3 107 cells/ml. Three hundred microliters of this cell suspen- Chin, K.-C., Li, G.X., and Ting, J.P.-Y. (1997). Importance of acidic,
sion was added to an electroporation cuvette (0.4 cm electrode gap, proline/serine/threonine-rich, and GTP-binding regions in the MHC
Biorad, Melville, NY) and mixed with the DNA of interest (10 mg of class II transactivator (CIITA): generation of trans-dominant-nega-
reporter and 10 mg of expression plasmids). Cells were electropor- tive mutants. Proc. Natl. Acad. Sci. USA 94, 2501±2506.
ated using the Gene Pulser apparatus (Biorad) at 200 V and 960 mF.
Chin, K.-C., Mao, C., Skinner, C., Riley, J.L., Wright, K.L., Moreno,
Electroporated cells were added to 8 ml of complete media and
C.S, Stark, G.R., Boss, J.M., and Ting, J.P.-Y. (1994). Molecular
allowed to recover for approximately 42 hr before harvest for CAT
analysis of G1B and G3A IFNg mutants reveals that defects in CIITA
assay. For 2fTGH cells, cells were plated on 10 cm plates at 5 3 or RFX result in defective class II MHC and Ii gene induction. Immu-
105 cells/plate on the day before transfection. Transfection was done nity 1, 687±697.
via the CaPO4 method as described (Ausebel et al., 1987). Cells
Cresswell, P. (1994). Assembly, transport, and function of MHC classwere allowed to recover for approximately 42 hr before harvest for
II molecules. Annu. Rev. Immunol. 12, 259±293.CAT assay.
Cromme, F.V., van Bommel, P.F., Walboomers, J.M., Gallee, M.P.,Cell extracts were prepared by freeze±thaw lysis as previously
Stern, P. L., Kenemans, P., Helmerhorst, T.J., Stukart, M.J., anddescribed (Sherman et al., 1989). For CAT assay the protein concen-
Meijer, C.J. (1994). Differences in MHC and TAP-1 expression intration of each sample was determined by Protein Assay Reagent
cervical cancer lymph node metastases as compared with the pri-(Biorad), and equal amounts of protein were used in a given experi-
mary tumours. Br. J. Cancer 69, 1176±1181.ment (10±15 mg). CAT assays were performed as previously de-
scribed (Sherman et al., 1989). The thin-layer chromatography plates Denzin, L.K., and Cresswell, P. (1995). HLA-DM induces CLIP disso-
were quantitated by phosphor imaging (Molecular Dynamics, Sun- ciation from MHC class II alpha beta dimers and facilitates peptide
nyvale, CA). loading. Cell 82, 155±165.
Dever, T.E., Glynias, M.J., and Merrick, W.C. (1987). GTP-binding
Gel Shift Analysis domain: three consensus sequence elements with distinct spacing.
Nuclear extracts were prepared according to the method of Dignam Proc. Natl. Acad. Sci. USA 84, 1814±1818.
et al. (1983). Gel shift assays were as previously described (Martin
Dey, A., Thornton, A.M., Lonergan, M., Weissman, S.M., Chamber-and Weis, 1993). In brief, binding reactions were performed under
lain, J.W., and Ozato, K. (1992). Occupancy of upstream regulatorythe following conditions: 12 mM HEPES (pH 7.9), 12% glycerol, 60
sites in vivo coincides with major histocompatibility complex classmM KCl, 120 mM EDTA, 120mM PMSF, 300mM DTT, with 4.5 mg BSA,
I gene expression in mouse tissues. Mol. Cell Biol. 12, 3590±3599.2 mg poly (dI´dC), 0.2 pg double-stranded oligonucleotide probe
Dignam, J.D., Lebovitz, R.M., and Roeder, R.G. (1983). Accurate(100,000 cpm, end-labeled), and 25 mg nuclear extract. Reactions
transcription initiation by RNA pol II in a soluble extract from isolatedwere incubated 30 min at 308C and then run for 2 hr on a 4% native
mammalian nuclei. Nucleic Acids Res. 11, 1475±1488.polyacylamide gel (0.53 Tris-borate-EDTA). The oligonucleotides
used have been previously described (Dey et al., 1992). The se- Dolo, V., Adobati, E., Canevari, S., Picone, M.A., and Vittorelli, M.L.
quence of the H-2Kb site a plus strand was TTC TGT CCG GAC ACT (1995). Membrane vesicles shed into the extracellular medium by
GTT GAC GCG CAG TCA G; the sequence of the minus strand was human breast carcinoma cells carry tumor-associated surface anti-
CTG ACT GCG CGT CAA CAG TGT CCG GAC AGA A. gens. Clin. Exp. Metastasis 13, 277±286.
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